ZLD will bounce back FA easily puts it at 14c
*Patented!, Clinically validated, Cannabis medications treating autism and insomnia, TGA approved and US licenced on the shelves selling as we speak. Also expecting to launch into the EU and UK 2021
*OTC oral heath product just released with 2 more products due 2021
*age disorders (Parkinson's) medication, due end 2020
*Vascular disease (PAD) medication due 2021
*Chronic Pain (athlete's) Product due 2021
*Dermatology (5 product's) due 2021
*Opioid Sparing medication trials due 2021
cash in the bank and only just started creating revenue
next couple 4c's will see ZLD shine, if not; well before then on more product launches. Great short to med hold.
GLTA DYOR
- Forums
- ASX - Day Trading
- Morning Trading December 10
Morning Trading December 10, page-492
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)